___

• 1. Diagnostic and Statistical Manual of Mental Disorders (DSM-5). American Psychiatric Association. 5th ed. Arlington, United States. American Psychiatric Publishing, 2013.
• 2. Williams MT, Mugno B, Franklin M, Faber S. Symptom dimensions in obsessive-compulsive disorder: phenomenology and treatment outcomes with exposure and ritual prevention. Psychopathology. 2013;46(6):365-76.
• 3. Özen ME, Kalenderoğlu A, Çelik M, Örüm MH, Hocaoğlu Ç. Obsesif kompulsif bozukluk güçlendirme tedavisinde aripiprazol, klomipramin ve buspironun etkinliği: Retrospektif bir araştırma. Adıyaman Üni Sağlık Bilimleri Derg. 2019;5(1):1293-302.
• 4. Ruscio A, Stein D, Chiu W, Kessler R. The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry. 2010;15(1):53-63.
• 5. Yorulmaz O, Işık B. Cultural context, obsessive-compulsive disorder symptoms, and cognitions: a preliminary study of three Turkish samples living in different countries. Int J Psychol. 2011;46(2):136-43.
• 6. Karadaĝ F, Oguzhanoglu NK, Ozdel O, Ateşci FC, Amuk T. OCD symptoms in a sample of Turkish patients: a phenomenological picture. Depress Anxiety. 2006;23(3):145-52..
• 7. Yee K, Serrano D, Kando J, McElroy SL. A psychometric analysis and revalidation of the Yale-Brown Obsessive Compulsive Scale modified for Binge Eating in adults with binge eating disorder. Qual Life Res. 2019;28(12):3385-94.
• 8. Baer L. Factor analysis of symptom subtypes of obsessive-compulsive disorder and their relation to personality and tic disorders. J Clin Psychiatry. 1994;55 Suppl:18-23.
• 9. Leckman JF, Grice DE, Boardman J, Zhang H, Vitale A, Bondi C et al. Symptoms of obsessive-compulsive disorder. Am J Psychiatry. 1997;154(7):911-7.
• 10. Mataix-Cols D, Rauch S, Manzo P, Jenike M, Baer L. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. Am J Psychiatry. 1999;156(9):1216-409.
• 11. Abramowitz JS, Franklin ME, Schwartz SA, Furr JM. Symptom presentation and outcome of cognitive-behavioral therapy for obsessive compulsive disorder. J Consult Clin Psychol. 2003;71(6):1049-57.
• 12. Hodsgon RJ, Rachman S. Obsessional-compulsive complaints. Behav Res Ther. 1977;15(5):389-95.
• 13. Erol N, Savaşır I. Maudsley obsesif kompulsif soru listesi. XXIV. Ulusal Psikiyatri ve Nörolojik Bilimler Kongresi Bildiri Kitabı, 23 Eylül 1988, Ankara, Türkiye. Ankara: GATA Basımevi; 1988:107-14.
• 14. Benzina N, Mallet L, Burguière E, N'Diaye K, Pelissolo A. Cognitive dysfunction in obsessive-compulsive disorder. Curr Psychiatry Rep. 2016;18(9):80.
• 15. Örüm MH. The relationship between cognitive errors and psychiatric symptoms in obsessive-compulsive disorder. Med J Ankara Tr Res Hosp. 2020;53(1):29-35.
• 16. Örüm MH. Cognitive error characteristics of rumination and cleaning dimensions of obsessive-compulsive disorder. Anadolu Psikiyatri Derg. 2020;21(6):592-9.
• 17. O'Connor K, Todorov C, Robillard S, Borgeat F, Brault M. Cognitive-behaviour therapy and medication in the treatment of obsessive-compulsive disorder: a controlled study. Can J Psychiatry. 1999;44(1):64-71.
• 18. Olatunji BO, Davis ML, Powers MB, Smits JA. Cognitive-behavioral therapy for obsessive-compulsive disorder: a meta-analysis of treatment outcome and moderators. J Psychiatr Res. 2013;47(1):33-41.
• 19. Keeley ML, Storch EA, Merlo LJ, Geffken GR. Clinical predictors of response to cognitive-behavioral therapy for obsessive-compulsive disorder. Clin Psychol Rev. 2008;28(1):118-30.
• 20. Özdel K, Taymur I, Guriz SO, Tulaci RG, Kuru E, Turkcapar MH. Measuring cognitive errors using the cognitive distortions scale (CDS): Psychometric properties in clinical and non-clinical samples. Plos ONE. 2014;9(8):E105956.
• 21. Endicott J, Spitzer RL, Fleiss JL, Cohen J. The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry. 1976;33(6):766-71.
• 22. Alvarenga PG, do Rosario MC, Cesar RC, Manfro GG, Moriyama TS, Bloch MH et al. Obsessive-compulsive symptoms are associated with psychiatric comorbidities, behavioral and clinical problems: a population-based study of Brazilian school children. Eur Child Adolesc Psychiatry. 2016;25(2):175-82.
• 23. Alemany-Navarro M, Cruz R, Real E, Segalàs C, Bertolín S, Rabionet R et al. Looking into the genetic bases of OCD dimensions: a pilot genome-wide association study. Transl Psychiatry. 2020;10(1):151.
• 24. Julien D, O’Connor KP, Aardema CT. The specificity of belief domains in obsessive–compulsive symptom subtypes. Pers Individ Differ. 2006;41(7):1205-16.
• 25. Sookman D, Pinard G. Overestimation of threat and intolerance of uncertainty in obsessive compulsive disorder. In: Frost RO, Steketee G, eds. Cognitive Approaches to Obsessions and Compulsions: Theory, Assessment and Treatment. Oxford. Elsevier, 2002:63-89.
• 26. Lee HJ, Kwon SM. Two different types of obsession: autogenous obsessions and reactive obsessions. Behav Res Ther. 2003;41:11-29.
• 27. Tolin DF, Woods CM, Abramowitz JS. Relationship between obsessive beliefs and obsessive-compulsive symptoms. Cognit Ther Res. 2003;27:657-69.
• 28. Emmelkamp PMG, Aardema A. Metacognition, specific obsessive–compulsive beliefs and obsessive–compulsive behaviour. Clin Psychol Psychother. 1999;6:139-45.
• 29. Öst LG, Riise EN, Wergeland GJ, Hansen B, Kvale G. Cognitive behavioral and pharmacological treatments of OCD in children: A systematic review and meta-analysis. J Anxiety Disord. 2016;43:58-69.
• 30. O’Connor KP, Aardema F, Robillard S, Guay S, Pélissier MC, Todorov C et al. Cognitive behaviour therapy and medication in the treatment of obsessive–compulsive disorder. Acta Psychiatrica Scandinavica. 2006;113(5):408-19.